Related Experiment Video
Updated: Aug 18, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The changing "natural history" of symptomatic coronary artery disease: basis versus bias
Insights
Recent natural history studies may overestimate coronary heart disease survival improvements due to selection biases. Careful scrutiny for lead-time, referral, and incidence-prevalence biases is crucial for accurate comparisons.
Area of Science:
- Cardiology
- Epidemiology
- Medical Statistics
Background:
- National statistics and randomized trials show 20-30% reduction in ischemic heart disease mortality.
- Recent "natural history" studies suggest greater survival improvements in symptomatic coronary patients.
- Uncritical comparison of these studies may lead to overestimation of true survival gains.
Purpose of the Study:
- To identify and explain biases in natural history studies of coronary heart disease.
- To caution against overestimating survival improvements by comparing patients across different studies and eras.
- To advocate for careful scrutiny of natural history studies for selection biases.
Main Methods:
- Analysis of potential biases in the interpretation of natural history studies.
- Identification of lead-time bias, referral bias, and incidence-prevalence bias.
- Conceptual framework for comparing patient cohorts from different time periods.
Main Results:
- Lead-time bias: Earlier diagnosis increases survival duration irrespective of treatment efficacy.
- Referral bias: Differences in patient symptom severity and anatomy between study eras.
- Incidence-prevalence bias: Prevalence studies overrepresent slower-progressing disease survivors.
Conclusions:
- Natural history studies, while accurate intrinsically, are prone to biases when compared across different patient groups or time periods.
- Lead-time, referral, and incidence-prevalence biases can significantly inflate perceived survival improvements.
- Researchers must critically evaluate natural history studies for these biases before comparing findings to avoid overestimating therapeutic or diagnostic advancements.
Abstract:
In contrast to the 20 to 30% reduction in ischemic heart disease mortality that has been demonstrated by national mortality statistics and by several randomized controlled trials, an uncritical reading of recent "natural history" studies suggests far greater improvements in the survival of symptomatic coronary patients. Although the intrinsic accuracy of such natural history studies is not questioned, attempts to compare patients from different studies and different eras may greatly overestimate the true improvement in natural history because of at least 3 biases in the selection of cases from the spectrum of diseased patients. Because of lead-time bias, patients who are diagnosed earlier live longer regardless of whether interventions are efficacious. Because of referral bias, current patients may have symptoms or anatomy that place them at a different stage of severity than patients who were chosen for earlier studies. Because of incidence-prevalence bias, prevalence studies will be over-represented with survivors of previous incidence cohorts who have slower-progressing disease. We suggest that all natural history studies be carefully scrutinized for such biases before they are compared with each other.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies